High-dose amsacrine (AMSA) therapy of relapsed and refractory adult acute nonlymphocytic leukemia. A phase II study.

Source:http://linkedlifedata.com/resource/pubmed/id/6547566

Download in:

View as

General Info

PMID
6547566